The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801

  • Yaacov Richard Lawrence
  • , Rebecca Paulus
  • , Corey Langer
  • , Maria Werner-Wasik
  • , Mark K. Buyyounouski
  • , Ritsuko Komaki
  • , Mitchell Machtay
  • , Colum Smith
  • , Rita S. Axelrod
  • , Todd Wasserman
  • , Jeffrey D. Bradley
  • , Benjamin Movsas

    Research output: Contribution to journalArticlepeer-review

    27 Scopus citations

    Fingerprint

    Dive into the research topics of 'The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science